2.5425
price up icon2.01%   0.0525
 
loading
전일 마감가:
$2.49
열려 있는:
$2.52
하루 거래량:
59,439
Relative Volume:
0.19
시가총액:
$128.46M
수익:
$44.12M
순이익/손실:
$-156.25M
주가수익비율:
-0.8282
EPS:
-3.07
순현금흐름:
$-154.61M
1주 성능:
+1.20%
1개월 성능:
-12.11%
6개월 성능:
-48.37%
1년 성능:
-36.66%
1일 변동 폭
Value
$2.47
$2.57
1주일 범위
Value
$2.41
$2.76
52주 변동 폭
Value
$2.345
$6.40

2 Seventy Bio Inc Stock (TSVT) Company Profile

Name
명칭
2 Seventy Bio Inc
Name
전화
339-499-9300
Name
주소
60 BINNEY STREET, CAMBRIDGE
Name
직원
425
Name
트위터
Name
다음 수익 날짜
2024-12-12
Name
최신 SEC 제출 서류
Name
TSVT's Discussions on Twitter

TSVT을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
TSVT
2 Seventy Bio Inc
2.53 128.46M 44.12M -156.25M -154.61M -3.07
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
438.94 113.70B 10.63B -479.80M -1.35B -1.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
680.11 75.52B 13.85B 4.65B 3.32B 40.41
Biotechnology icon
ARGX
Argen X Se Adr
662.88 39.78B 1.86B -40.29M -1.28B -0.85
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
275.25 35.34B 2.09B -332.26M 16.06M -2.62
Biotechnology icon
BNTX
Biontech Se Adr
120.00 29.05B 3.30B -501.07M 1.03B -2.1146

2 Seventy Bio Inc Stock (TSVT) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2024-06-06 다운그레이드 Goldman Neutral → Sell
2024-01-31 업그레이드 Leerink Partners Market Perform → Outperform
2024-01-31 다운그레이드 TD Cowen Outperform → Market Perform
2023-10-30 다운그레이드 Leerink Partners Outperform → Market Perform
2023-10-12 개시 Citigroup Buy
2023-09-13 다운그레이드 Goldman Buy → Neutral
2023-09-12 다운그레이드 Guggenheim Buy → Neutral
2023-07-28 다운그레이드 Morgan Stanley Overweight → Equal-Weight
2022-10-31 개시 Guggenheim Buy
2022-05-02 개시 Goldman Buy
2022-02-10 개시 SVB Leerink Outperform
2022-01-06 개시 Cowen Outperform
2021-11-09 개시 Canaccord Genuity Buy
2021-11-08 개시 Morgan Stanley Overweight
2021-11-08 개시 Wedbush Outperform
모두보기

2 Seventy Bio Inc 주식(TSVT)의 최신 뉴스

pulisher
Jan 24, 2025

Layoff Tracker: Biogen to Cut Undisclosed Number of Research Employees - BioSpace

Jan 24, 2025
pulisher
Jan 20, 2025

Weiss Ratings Reaffirms “Sell (E+)” Rating for 2seventy bio (NASDAQ:TSVT) - Defense World

Jan 20, 2025
pulisher
Jan 04, 2025

Barclays PLC Sells 132,019 Shares of 2seventy bio, Inc. (NASDAQ:TSVT) - Defense World

Jan 04, 2025
pulisher
Dec 18, 2024

Fmr LLC Has $701,000 Stock Holdings in 2seventy bio, Inc. (NASDAQ:TSVT) - Defense World

Dec 18, 2024
pulisher
Nov 15, 2024

Analysts Have Been Trimming Their 2seventy bio, Inc. (NASDAQ:TSVT) Price Target After Its Latest Report - Simply Wall St

Nov 15, 2024
pulisher
Nov 12, 2024

2seventy bio Reports Third Quarter Financial Results and Recent Operational Progress - Business Wire

Nov 12, 2024
pulisher
Nov 06, 2024

Barinthus Bio Reports Third Quarter 2024 Update on Corporate Developments and Financial Results - GlobeNewswire

Nov 06, 2024
pulisher
Nov 04, 2024

2seventy bio to Report Third Quarter 2024 Financial Results and Participate in Upcoming Investor Conference - Business Wire

Nov 04, 2024
pulisher
Oct 22, 2024

2seventy bio, Inc. (NASDAQ:TSVT) Shares Sold by Exchange Traded Concepts LLC - Defense World

Oct 22, 2024
pulisher
Oct 17, 2024

BioAegis Therapeutics Enrolls First Patient in Phase 2 Clinical Trial of Gelsolin, an Immune Regulator, for the Treatment of Acute Respiratory Distress Syndrome (ARDS) - Yahoo Finance

Oct 17, 2024
pulisher
Oct 14, 2024

Dimensional Fund Advisors LP Sells 24,371 Shares of 2seventy bio, Inc. (NASDAQ:TSVT) - Defense World

Oct 14, 2024
pulisher
Oct 09, 2024

TSVT INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into 2seventy bio, Inc. and Encourages Investors to Contact the Firm - GlobeNewswire Inc.

Oct 09, 2024
pulisher
Sep 27, 2024

BMS and 2seventy bio Axe Trial for Ide-Cel in Newly Diagnosed Multiple Myeloma - CGTLive™

Sep 27, 2024
pulisher
Sep 25, 2024

2seventy bio Provides Update on KarMMa-9 Study and Previews Anticipated Strong Third Quarter Revenue Performance - Business Wire

Sep 25, 2024
pulisher
Sep 24, 2024

Seven Eight Capital LP Makes New $197,000 Investment in Beyond, Inc. (NYSE:BYON) - Defense World

Sep 24, 2024
pulisher
Sep 24, 2024

Q&A: Athens legends Five Eight and the makers of their new documentary film, "Weirdo" - Online Athens

Sep 24, 2024
pulisher
Sep 22, 2024

Four killed, dozens injured in Alabama mass shooting - Daily Sun

Sep 22, 2024
pulisher
Sep 22, 2024

Seven Eight Capital LP Sells 536 Shares of Dell Technologies Inc. (NYSE:DELL) - Defense World

Sep 22, 2024
pulisher
Sep 22, 2024

Four dead, 17 others shot in Birmingham mass shooting - WJLA

Sep 22, 2024
pulisher
Sep 22, 2024

Five Below, Inc. (NASDAQ:FIVE) Stake Raised by Teca Partners LP - Defense World

Sep 22, 2024
pulisher
Sep 22, 2024

Four killed, over 20 injured in Birmingham, Alabama shooting - Thaiger World

Sep 22, 2024
pulisher
Sep 22, 2024

At least four dead and dozens injured in shootout with multiple assailants in the United States - Top Buzz Times

Sep 22, 2024
pulisher
Sep 22, 2024

Four people dead and dozens injured in US mass shooting horror - Express

Sep 22, 2024
pulisher
Sep 21, 2024

Analyst bullish on Tectonic's TX45 ahead of full trial results presentation at AHA - Investing.com India

Sep 21, 2024
pulisher
Sep 19, 2024

Tectonic Therapeutic Announces Favorable Phase 1a Safety, Tolerability and PK/PD Results for Lead Program TX45 - GlobeNewswire

Sep 19, 2024
pulisher
Sep 19, 2024

Hedge fund Two Sigma in settlement talks with US SEC, WSJ reports - XM

Sep 19, 2024

2 Seventy Bio Inc (TSVT) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading

2 Seventy Bio Inc 주식 (TSVT) 내부자 거래

내부자 거래 관계 날짜 거래 비용 #주식 가치 ($) #주식 총계
Snow Jessica
See Remarks
Jan 03 '25
Sale
2.94
1,000
2,936
152,479
Snow Jessica
See Remarks
Jan 07 '25
Sale
2.64
186
491
147,179
Leschly Nick
Director
Jan 03 '25
Sale
2.94
85,978
252,423
1,234,498
Leschly Nick
Director
Jan 06 '25
Sale
2.78
892
2,478
1,233,606
Eatwell Victoria
Chief Financial Officer
Jan 03 '25
Sale
2.94
1,013
2,974
339,076
Eatwell Victoria
Chief Financial Officer
Jan 06 '25
Sale
2.78
97
270
338,979
Baird William D III
President and CEO
Jan 03 '25
Sale
2.94
31,718
93,121
862,889
Baird William D III
President and CEO
Jan 06 '25
Sale
2.78
763
2,120
862,126
Snow Jessica
See Remarks
Dec 13 '24
Sale
3.23
2,287
7,393
153,479
$40.87
price up icon 0.45%
$22.30
price up icon 3.17%
$353.35
price down icon 5.38%
$5.3824
price up icon 3.31%
biotechnology ONC
$228.12
price up icon 0.53%
$120.53
price down icon 0.02%
자본화:     |  볼륨(24시간):